: Court strikes down federal rule that sharply increased prescription costs for many patients

Drugmakers’ copay assistance is at issue in patient-advocacy groups’ lawsuit.

Previous post : Dow, S&P 500 set to extend last week’s losses in Monday’s final hour of trading
Next post The Human Cost: $24 billion in pandemic-era funding for child care just expired. Will it impact your family?